Skip to main content
. 2012 Dec 17;11:420. doi: 10.1186/1475-2875-11-420

Table 4.

Subjects with QTc >60 ms from baseline based on different QT correction formulae

Age (yrs) Sex Drug QTc day 0 (ms) QTc day 3 (ms) Δ QTc(day3-day0) DEAQ (ng/ml)
3.5
Male
A-A
361B
413B
52
109
 
 
 
315F
379F
64
 
 
 
 
373H
390H
17
 
5.5
Female
A-A
353B
399B
46
162
 
 
 
310F
386F
76
 
 
 
 
363H
385H
22
 
6.0
Female
A-A
404B
464B
60
0
 
 
 
357F
426F
69
 
 
 
 
394H
430H
36
 
6.5
Male
A-A
361B
443B
82
241
 
 
 
315F
397F
82
 
 
 
 
373H
416H
43
 
9.0
Male
A-L
366B
443B
77
NA
 
 
 
335F
413F
78
 
 
 
 
355H
414H
59
 
10.0
Female
A-L
387B
450B
63
NA
 
 
 
347F
418F
71
 
      376H 419H 43  

B=Bazett’s QTc; F=Fridericia’s QTC; H=Hodges QTc; ΔQTc =change in QTc; A-A=artesunate-amodiaquine; A-L=artemether-lumefantrine; DEAQ=desethylamodiaquine concentration; NA=Not applicable.